MedPath

Study of the clinical outcome of Goreisan in patients with abnormal fluid retention.

Not Applicable
Recruiting
Conditions
Abnormal fluid retention
Registration Number
JPRN-UMIN000032889
Lead Sponsor
Tokorozawa Heart Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients younger than 20 years old 2) Patients who have allergy for cinnamon 3) Patients who are pregnant or hope to be pregnant 4) Patients who cannot take oral administration 5) Patients who have no urination due to end-stage renal failure on hemodialysis 6) Patients who are not expected to react to diuretics due to acute kidney injury 7) Patients who participate in another interventional trial 8) Patients whose doctor in charge do not agree to join the trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A total of 3days urine volume form the day after participation in this study.
Secondary Outcome Measures
NameTimeMethod
Serum creatinine, electrolyte, liver enzyme, body weight, and the degree of peripheral edema.
© Copyright 2025. All Rights Reserved by MedPath